Biological results revealed altered tumor markers (CA 19-9 = 78.9, CEA = 9.9, NSE = 40.1), corrected hypokalemia, corrected hyponatremia, altered urinalysis, elevated cardiac enzymes, biological inflammatory syndrome, and elevated blood glucose. The gene discussed is ENO2; the disease is neoplasm.